Final results of randomized study of gemcitabine (G) plus cisplatin (P) versus etoposide (E) plus cisplatin in locally advanced or metastatic non small cell lung cancer (NSCLC)

被引：0
|
作者：
Bousahba, A., Sr. [1 ]
Bereksi-Reguig, F. [1 ]
Seghier, F. [1 ]
Boukerche, A. [1 ]
Dali-Youcef, A. [1 ]
Djellali, L. [1 ]
机构：
[1] Natl Inst Med, Oran, Algeria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19006
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer
    Noda, W
    Nishiwaki, Y
    Kawahara, M
    Negoro, S
    Sugiura, T
    Yokoyama, A
    Fukuoka, M
    Mori, K
    Watanabe, K
    Tamura, T
    Yamamoto, S
    Saijo, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (02): : 85 - 91
  • [42] A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: A cancer and leukemia group B study
    Graziano, SL
    Valone, FH
    Herndon, JE
    Crawford, J
    Richards, F
    Rege, VB
    Clamon, G
    Green, MR
    [J]. LUNG CANCER, 1996, 14 (2-3) : 315 - 329
  • [43] Cisplatin (P)-including triplets versus P-free doublets in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC): Final results of the SICOG 0101 randomized trial
    Comella, P.
    Palmeri, S.
    De Cataldis, G.
    Filippelli, G.
    Cioffi, R.
    Farris, A.
    Maiorino, L.
    Massidda, B.
    Roselli, M.
    Gambardella, A.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI24 - XI24
  • [44] The activity of gemcitabine plus cisplatin in randomized trials in untreated patients with advanced non-small cell lung cancer
    Rosell, R
    Tonato, M
    Sandler, A
    [J]. SEMINARS IN ONCOLOGY, 1998, 25 (04) : 27 - 34
  • [45] Gemcitabine plus docetaxel for advanced or metastatic non-small cell lung cancer: Similar survival to cisplatin plus vinorelbine and less toxicity
    Solomon, B
    Bunn, PA
    [J]. CANCER TREATMENT REVIEWS, 2005, 31 (07) : 571 - 576
  • [46] A comparative study of combination chemotherapy with docetaxel/cisplatin versus gemcitabine/cisplatin for locally advanced non-small cell lung cancer
    El-Nashar, E
    [J]. LUNG CANCER, 2005, 49 : S243 - S243
  • [47] A cost analysis of treatment with bevacizumab plus cisplatin and gemcitabine (BCG) versus cetuximab plus vinorelbine and cisplatin (CVC) in patients with advanced or recurrent non-small cell lung cancer (NSCLC) in Germany
    Heigener, D. F.
    Wiesner, C.
    Aultman, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer
    Manegold, C
    Bergman, B
    Chemaissani, A
    Dornoff, W
    Drings, P
    KellokumpuLehtinen, P
    Liippo, K
    Mattson, K
    vonPawel, J
    Ricci, S
    Sederholm, C
    Stahel, RA
    Wagenius, G
    vonWalree, N
    tenBokkelHuinink, W
    [J]. ANNALS OF ONCOLOGY, 1997, 8 (06) : 525 - 529
  • [49] ETOPOSIDE VERSUS ETOPOSIDE PLUS HIGH-DOSE CISPLATIN IN THE MANAGEMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - RESULTS OF A PROSPECTIVE RANDOMIZED FONICAP TRIAL
    ROSSO, R
    SALVATI, F
    ARDIZZONI, A
    CURCIO, CG
    RUBAGOTTI, A
    BELLI, M
    CASTAGNETO, B
    FUSCO, V
    SASSI, M
    FERRARA, G
    PIZZA, A
    PEDICINI, T
    SORESI, E
    SCODITTI, S
    CIOFFI, R
    FOLCO, U
    MONACO, M
    MERLANO, M
    RIMOLDI, R
    TONACHELLA, R
    CRUCIANI, A
    COLANTUONI, G
    RINALDI, M
    PORTALONE, L
    BRUZZI, P
    SANTI, L
    [J]. CANCER, 1990, 66 (01) : 130 - 134
  • [50] Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer
    Asamoto, H
    Kawahara, M
    Iwami, F
    Kuba, M
    Furuse, K
    Tamura, T
    Saijo, N
    Shimoyama, M
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (12) : 745 - 748
12345